Research programme: cancer therapeutics - China Sky One MedicalAlternative Names: Endostatin - China Sky One Medical; Endothelin-1
Latest Information Update: 09 Mar 2011
At a glance
- Originator Harbin Medical University
- Developer China Sky One Medical
- Class Proteins
- Mechanism of Action Angiogenesis inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 09 Mar 2011 Preclinical development is ongoing in China
- 08 Sep 2008 Preclinical trials in Cancer in China (unspecified route)